Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs)

ACS Medicinal Chemistry Letters

Volumn 7, Issue 1, 2016, Pages 83-88

  Handlon, Anthony L ^a   Schaller, Lee T ^a   Leesnitzer, Lisa M ^a   Merrihew, Raymond V ^a   Poole, Chuck ^a   Ulrich, John C ^a   Wilson, Joseph W ^a   Cadilla, Rodolfo ^a   Turnbull, Philip ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

androgen receptor; ligand efficiency; LLE; SARM; selective androgen receptor modulator

Indexed keywords

ANDROGEN RECEPTOR; SELECTIVE ANDROGEN RECEPTOR MODULATOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84955452804     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00377     Document Type: Article

References (22)

1. Karakelides, H.; Nair, K. S. Sarcopenia of aging and its metabolic impact Curr. Top. Dev. Biol. 2005, 68, 123-148 10.1016/S0070-2153(05)68005-2
2. von Haehling, S.; Anker, S. D. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014 J. Cachexia Sarcopenia Muscle 2014, 5, 261-263 10.1007/s13539-014-0164-8
3. Hughes, V. A.; Frontera, W. R.; Roubenoff, R.; Evans, W. J.; Singh, M. A. F. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity Am. J. Clin. Nutr. 2002, 76, 473-481
4. Mekary, R. A.; Grontved, A.; Despres, J. P.; De Moura, L. P.; Asgarzadeh, M.; Willett, W. C.; Rimm, E. B.; Giovannucci, E.; Hu, F. B. Weight training, aerobic physical activities, and long-term waist circumference change in men Obesity 2015, 23, 461 10.1002/oby.20949
5. Morley, J. E.; von Haehling, S.; Anker, S. D. Are we closer to having drugs to treat muscle wasting disease? J. Cachexia Sarcopenia Muscle 2014, 5, 83-87 10.1007/s13539-014-0149-7
6. Brown-Séquard Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals Lancet 1889, 134, 105-107 10.1016/S0140-6736(00)64118-1
7. Cadilla, R.; Turnbull, P. Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential Curr. Top. Med. Chem. 2006, 6, 245-270 10.2174/156802606776173456
8. Gao, W.; Dalton, J. T. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) Drug Discovery Today 2007, 12, 241-248 10.1016/j.drudis.2007.01.003
9. Steiner, M. S.; Barnette, K. G.; Hancock, M. L.; Dodson, S. T.; Rodriguez, D.; Morton, R. A. Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia ASCO Meeting Abstracts 2010, 28, 9147
10. Dalton, J. T.; Barnette, K. G.; Bohl, C. E.; Hancock, M. L.; Rodriguez, D.; Dodson, S. T.; Morton, R. A.; Steiner, M. S. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial J. Cachexia Sarcopenia Muscle 2011, 2, 153-161 10.1007/s13539-011-0034-6
11. Basaria, S.; Collins, L.; Dillon, E. L.; Orwoll, K.; Storer, T. W.; Miciek, R.; Ulloor, J.; Zhang, A.; Eder, R.; Zientek, H.; Gordon, G.; Kazmi, S.; Sheffield-Moore, M.; Bhasin, S. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men J. Gerontol., Ser. A 2013, 68, 87-95 10.1093/gerona/gls078
12. Chekler, E. L. Tissue selective androgen receptor modulators (SARMs): A path to a clinical candidate. Abstracts of Papers, 250th ACS National Meeting & Exposition, Boston, MA, United States, August 16-20, 2015; MEDI-345.
13. Study To Evaluate Safety And Tolerability of Single and Multiple Ascending Doses of PF-06260414 in Healthy Western and Japanese Male Subjects. www.clinicaltrials.gov/ct2/show/NCT02070939 (accessed April 16, 2015).
14. Product Pipeline. www.pfizer.com/pipeline (accessed July 28, 2015).
15. Harikrishna, K.; Rakshit, A.; Aidhen, I. S. Study of the chemoselectivity of Grignard reagent addition to substrates containing both nitrile and Weinreb amide functionalities Eur. J. Org. Chem. 2013, 2013, 4918-4932 10.1002/ejoc.201300622
16. Shidlovskii, A. F.; Golubev, A. S.; Gusev, D. V.; Suponitsky, K. Y.; Peregudov, A. S.; Chkanikov, N. D. A new synthesis of N-substituted-trifluoroacetylanilines J. Fluorine Chem. 2012, 143, 272-280 10.1016/j.jfluchem.2012.07.002
17. Ahvazi, B. C.; Argyropoulos, D. S. 19F Nuclear magnetic resonance spectroscopy for the elucidation of carbonyl groups in lignins. 1. Model compounds J. Agric. Food Chem. 1996, 44, 2167-2175 10.1021/jf960154r
18. Walkowiak, J.; del Campo, T.; Ameduri, B.; Gouverneur, V. Syntheses of mono-, di-, and trifluorinated styrenic monomers Synthesis 2010, 2010, 1883-1890 10.1055/s-0029-1218785
19. Sharma, A. K.; Subramani, A. V.; Gorman, C. B. Efficient synthesis of halo indanones via chlorosulfonic acid mediated Friedel-Crafts cyclization of aryl propionic acids and their use in alkylation reactions Tetrahedron 2007, 63, 389-395 10.1016/j.tet.2006.10.065
20. Cube, R. V.; Vernier, J. M.; Hutchinson, J. H.; Gardner, M. F.; James, J. K.; Rowe, B. A.; Schaffhauser, H.; Daggett, L.; Pinkerton, A. B. 3-(2-Ethoxy-4-phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2) Bioorg. Med. Chem. Lett. 2005, 15, 2389-2393 10.1016/j.bmcl.2005.02.078
21. Murray, C. W.; Erlanson, D. A.; Hopkins, A. L.; Keseru, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H.; Richmond, N. J. Validity of ligand efficiency metrics ACS Med. Chem. Lett. 2014, 5, 616-618 10.1021/ml500146d
22. Hopkins, A. L.; Keserue, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. The role of ligand efficiency metrics in drug discovery Nat. Rev. Drug Discovery 2014, 13, 105-121 10.1038/nrd4163